Facebook tracking pixel
I70.203
ICD-10-CM
Aortoiliac Disease

Understanding Aortoiliac Disease (Leriche Syndrome) diagnosis, symptoms, and treatment is crucial for accurate clinical documentation and medical coding. Find information on Aortoiliac Occlusive Disease, including ICD-10 codes, healthcare guidelines, and best practices for medical professionals. This resource helps ensure proper documentation and coding for Aortoiliac Disease, supporting optimal patient care and accurate reimbursement.

Also known as

Leriche Syndrome
Aortoiliac Occlusive Disease

Diagnosis Snapshot

Key Facts
  • Definition : Narrowing or blockage of the aorta and iliac arteries, reducing blood flow to the legs and pelvis.
  • Clinical Signs : Leg pain (claudication), buttock pain, erectile dysfunction, absent femoral pulses.
  • Common Settings : Vascular surgery clinics, cardiology, interventional radiology.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC I70.203 Coding
I70-I79

Diseases of arteries, arterioles and capillaries

Covers various arterial diseases, including aortoiliac conditions.

I70

Atherosclerosis

Relates to atherosclerosis, a common cause of aortoiliac disease.

I73

Peripheral vascular disease

Encompasses peripheral arterial issues, sometimes linked to aortoiliac disease.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the aortoiliac disease due to atherosclerosis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Peripheral artery disease affecting the aorta and iliac arteries.
Peripheral artery disease affecting lower extremities, excluding aorta/iliac.
Narrowing or blockage in the femoral artery.

Documentation Best Practices

Documentation Checklist
  • Document location, severity, and laterality of aortoiliac stenosis/occlusion.
  • Specify disease impact on blood flow (e.g., reduced, absent).
  • Record symptoms: claudication, impotence, absent pulses.
  • Include diagnostic testing results (e.g., ABI, angiography).
  • If Leriche Syndrome, document triad: claudication, impotence, absent femoral pulses.

Coding and Audit Risks

Common Risks
  • Unspecified Location

    Aortoiliac disease coding requires specifying the affected segment (e.g., infrarenal aorta) for accurate reimbursement.

  • Confusing Etiology

    Differentiating aortoiliac disease from other occlusive diseases (e.g., atherosclerosis) is crucial for proper coding and CDI.

  • Missing Laterality

    Documenting laterality (right, left, or bilateral) is essential for aortoiliac interventions to avoid coding errors and claim denials.

Mitigation Tips

Best Practices
  • Document claudication symptoms, ABI scores for ICD-10 I70.2
  • Capture Leriche triad for accurate coding (I70.20, I70.29)
  • Specify disease location (aorta, iliac) in operative reports
  • Query physician for disease etiology (atherosclerosis vs. other)
  • Review documentation for PAD severity for HCC risk adjustment

Clinical Decision Support

Checklist
  • Verify diminished or absent femoral pulses (ICD-10 I70.2)
  • Check for symptoms: claudication, buttock pain, ED (SNOMED CT 440214000)
  • Confirm via imaging: duplex ultrasound, CTA, MRA (CPT 93976)
  • Assess ankle-brachial index (ABI) < 0.9 (LOINC 45062-8)

Reimbursement and Quality Metrics

Impact Summary
  • Aortoiliac Disease reimbursement hinges on accurate ICD-10 coding (I70.2) for optimal claims processing and reduced denials.
  • Coding quality directly impacts hospital reporting on vascular disease prevalence and treatment outcomes for performance metrics.
  • Proper documentation of Leriche Syndrome or Aortoiliac Occlusive Disease ensures appropriate MS-DRG assignment and accurate reimbursement.
  • Accurate coding and documentation improve data integrity for quality reporting initiatives and value-based care programs.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the key differentiating diagnostic features between aortoiliac occlusive disease and other causes of lower extremity claudication in older adults?

A: Differentiating aortoiliac occlusive disease (also known as Leriche syndrome) from other causes of lower extremity claudication, such as lumbar spinal stenosis or peripheral artery disease isolated to the femoropopliteal segment, requires a thorough clinical evaluation. In aortoiliac disease, patients typically present with claudication affecting the buttocks, thighs, and calves, often with absent or diminished femoral pulses. Impotence may be present in males. Contrast-enhanced CT or MR angiography can accurately visualize the aortoiliac segment and confirm the diagnosis, revealing stenosis or occlusion. Distinguishing it from lumbar spinal stenosis involves careful neurological examination, focusing on symptoms exacerbated by extension and relieved by flexion of the spine. While both conditions may cause pain during exercise, the location and character differ. Differentiating it from femoropopliteal PAD relies on evaluating pulses below the inguinal ligament, which are typically preserved in isolated femoropopliteal disease. Explore how advanced imaging modalities can aid in accurate diagnosis and assessment of disease severity in aortoiliac occlusive disease.

Q: How does current clinical practice guideline recommend managing asymptomatic aortoiliac disease discovered incidentally during abdominal imaging?

A: Current clinical practice guidelines for managing incidentally discovered asymptomatic aortoiliac disease emphasize a conservative approach initially. Risk factor modification, including smoking cessation, controlling hypertension, diabetes management, and lipid-lowering therapy, are paramount. Regular exercise is also recommended to promote collateral circulation. Close surveillance with periodic ankle-brachial index (ABI) measurements and duplex ultrasound is often employed to monitor disease progression. Intervention, such as endovascular angioplasty or surgical bypass, is generally reserved for patients who develop symptoms or show signs of significant disease progression. Consider implementing a structured surveillance program for asymptomatic patients to ensure timely intervention if needed. Learn more about the role of risk factor modification in slowing the progression of aortoiliac disease.

Quick Tips

Practical Coding Tips
  • Code I70.261 for aortoiliac occlusion
  • Document claudication symptoms
  • Query physician for disease severity
  • Check for ICD-10-CM updates
  • Review medical records for laterality

Documentation Templates

Patient presents with symptoms suggestive of aortoiliac disease (also known as Leriche syndrome or aortoiliac occlusive disease).  Presenting complaints include intermittent claudication characterized by buttock, thigh, or calf pain with exertion, relieved by rest.  Physical exam reveals diminished or absent femoral pulses, cool lower extremities, and potential evidence of peripheral artery disease such as skin changes including pallor, rubor, or hair loss.  Differential diagnosis includes lumbar spinal stenosis, peripheral neuropathy, and other causes of peripheral vascular disease.  Diagnostic workup may include ankle-brachial index (ABI) measurement, duplex ultrasound of the aortoiliac vessels, CT angiography, or magnetic resonance angiography (MRA) to assess the degree of stenosis or occlusion.  Assessment includes evaluating for risk factors such as hypertension, hyperlipidemia, diabetes mellitus, smoking history, and family history of atherosclerosis.  Treatment plan may involve lifestyle modifications including smoking cessation, exercise therapy, and dietary changes.  Pharmacological management may include antiplatelet agents, statins, and medications to control blood pressure and diabetes.  Interventional procedures such as angioplasty, stenting, or aortofemoral bypass surgery may be considered depending on the severity of the disease and patient's overall health status.  Patient education regarding the disease process, risk factor modification, and medication adherence will be provided.  Follow-up appointments will be scheduled to monitor disease progression and treatment efficacy.